Literature DB >> 25830527

An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.

Bartolome R Celli, Marc Decramer, Jadwiga A Wedzicha, Kevin C Wilson, Alvar Agustí, Gerard J Criner, William MacNee, Barry J Make, Stephen I Rennard, Robert A Stockley, Claus Vogelmeier, Antonio Anzueto, David H Au, Peter J Barnes, Pierre-Regis Burgel, Peter M Calverley, Ciro Casanova, Enrico M Clini, Christopher B Cooper, Harvey O Coxson, Daniel J Dusser, Leonardo M Fabbri, Bonnie Fahy, Gary T Ferguson, Andrew Fisher, Monica J Fletcher, Maurice Hayot, John R Hurst, Paul W Jones, Donald A Mahler, François Maltais, David M Mannino, Fernando J Martinez, Marc Miravitlles, Paula M Meek, Alberto Papi, Klaus F Rabe, Nicolas Roche, Frank C Sciurba, Sanjay Sethi, Nikos Siafakas, Don D Sin, Joan B Soriano, James K Stoller, Donald P Tashkin, Thierry Troosters, Geert M Verleden, Johny Verschakelen, Jorgen Vestbo, John W Walsh, George R Washko, Robert A Wise, Emiel F M Wouters, Richard L ZuWallack.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic Society (ATS)/European Respiratory Society (ERS) Research Statement is to describe evidence related to diagnosis, assessment, and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management.
METHODS: Clinicians, researchers, and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarized, and then salient knowledge gaps were identified.
RESULTS: Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus.
CONCLUSIONS: Great strides have been made in the diagnosis, assessment, and management of COPD as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS Research Statement highlights the types of research that leading clinicians, researchers, and patient advocates believe will have the greatest impact on patient-centered outcomes.

Entities:  

Mesh:

Year:  2015        PMID: 25830527     DOI: 10.1164/rccm.201501-0044ST

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  63 in total

1.  Positive Airway Pressure Therapies and Hospitalization in Chronic Obstructive Pulmonary Disease.

Authors:  Monica M Vasquez; Leslie A McClure; Duane L Sherrill; Sanjay R Patel; Jerry Krishnan; Stefano Guerra; Sairam Parthasarathy
Journal:  Am J Med       Date:  2017-01-13       Impact factor: 4.965

2.  Adding Pedometers to Pulmonary Rehabilitation Did Not Result in Greater Physical Activity. An Important Answer, but What Was the Question?

Authors:  Carlos H Martinez
Journal:  Am J Respir Crit Care Med       Date:  2017-05-15       Impact factor: 21.405

Review 3.  Potential impact of a Moraxella catarrhalis vaccine in COPD.

Authors:  Antonia C Perez; Timothy F Murphy
Journal:  Vaccine       Date:  2017-02-06       Impact factor: 3.641

4.  Work Practices and Respiratory Health Status of Appalachian Coal Miners With Progressive Massive Fibrosis.

Authors:  Laura E Reynolds; David J Blackley; Jay F Colinet; J Drew Potts; Eileen Storey; Connie Short; Ron Carson; Kathleen A Clark; A Scott Laney; Cara N Halldin
Journal:  J Occup Environ Med       Date:  2018-11       Impact factor: 2.162

5.  Incidence of Acute Cardiovascular Event After Acute Exacerbation of COPD.

Authors:  Tadahiro Goto; Yuichi J Shimada; Mohammad Kamal Faridi; Carlos A Camargo; Kohei Hasegawa
Journal:  J Gen Intern Med       Date:  2018-06-08       Impact factor: 5.128

6.  Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.

Authors:  Robert A Wise; Russell A Acevedo; Antonio R Anzueto; Nicola A Hanania; Fernando J Martinez; Jill A Ohar; Donald P Tashkin
Journal:  Chronic Obstr Pulm Dis       Date:  2016-11-15

7.  High-Dose Versus Low-Dose Systemic Steroids in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Systematic Review.

Authors:  Diego Bonilla Arcos; Jerry A Krishnan; R William Vandivier; Jonathan E Sevransky; William Checkley; Tyree H Kiser; Jamie L Sullivan; John W Walsh; Robert A Wise; Kevin C Wilson
Journal:  Chronic Obstr Pulm Dis       Date:  2016-02-17

8.  Editorial: Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases.

Authors:  Michael R Jacobs; Gerard J Criner
Journal:  Chronic Obstr Pulm Dis       Date:  2015-04-30

9.  Anatomically Based Analysis of Radioaerosol Distribution in Pulmonary Scintigraphy: A Feasibility Study in Asthmatics.

Authors:  Luciana Alcoforado; Armèle Dornelas de Andrade; Joaquin L Herraiz; Simone Cristina Soares Brandão; Jacqueline de Melo Barcelar; James B Fink; Jose G Venegas
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2018-04-19       Impact factor: 2.849

10.  Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease.

Authors:  Esther Pompe; Craig J Galbán; Brian D Ross; Leo Koenderman; Nick Ht Ten Hacken; Dirkje S Postma; Maarten van den Berge; Pim A de Jong; Jan-Willem J Lammers; Firdaus Aa Mohamed Hoesein
Journal:  Respir Med       Date:  2016-11-25       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.